Researchers seek better way to predict hormone therapy success in breast cancer
NCT ID NCT06806930
Summary
This study aims to understand how the length of hormone-blocking therapy before breast cancer surgery affects treatment outcomes. Researchers will analyze blood and tissue samples from 90 participants with early-stage breast cancer to predict which patients will respond best to this approach. The goal is to help doctors better tailor treatment timing based on individual patient responses.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER STAGE I are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
George Washington-Medical Faculty Associates
RECRUITINGWashington D.C., District of Columbia, 20037, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.